These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 18175273)

  • 1. Positron emission tomography for use in microdosing studies.
    Wagner CC; Müller M; Lappin G; Langer O
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Big physics, small doses: the use of AMS and PET in human microdosing of development drugs.
    Lappin G; Garner RC
    Nat Rev Drug Discov; 2003 Mar; 2(3):233-40. PubMed ID: 12612650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microdosing studies in humans: the role of positron emission tomography.
    Bauer M; Wagner CC; Langer O
    Drugs R D; 2008; 9(2):73-81. PubMed ID: 18298126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches using molecular imaging technology -- use of PET in clinical microdose studies.
    Wagner CC; Langer O
    Adv Drug Deliv Rev; 2011 Jun; 63(7):539-46. PubMed ID: 20887762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging with SPECT as a tool for drug development.
    Gomes CM; Abrunhosa AJ; Ramos P; Pauwels EK
    Adv Drug Deliv Rev; 2011 Jun; 63(7):547-54. PubMed ID: 20933557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiopharmaceuticals: molecular imaging using positron emission tomography.
    Antoni G; Långström B
    Handb Exp Pharmacol; 2008; (185 Pt 1):177-201. PubMed ID: 18626804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry.
    Balani SK; Nagaraja NV; Qian MG; Costa AO; Daniels JS; Yang H; Shimoga PR; Wu JT; Gan LS; Lee FW; Miwa GT
    Drug Metab Dispos; 2006 Mar; 34(3):384-8. PubMed ID: 16326814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-animal PET: a promising, non-invasive tool in pre-clinical research.
    Schnöckel U; Hermann S; Stegger L; Law M; Kuhlmann M; Schober O; Schäfers K; Schäfers M
    Eur J Pharm Biopharm; 2010 Jan; 74(1):50-4. PubMed ID: 19482080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small animal PET in preclinical studies: opportunities and challenges.
    Riemann B; Schäfers KP; Schober O; Schäfers M
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):215-21. PubMed ID: 18551093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New ultrasensitive detection technologies and techniques for use in microdosing studies.
    Lappin G; Wagner CC; Langer O; van de Merbel N
    Bioanalysis; 2009 May; 1(2):357-66. PubMed ID: 21083172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using positron emission tomography to facilitate CNS drug development.
    Lee CM; Farde L
    Trends Pharmacol Sci; 2006 Jun; 27(6):310-6. PubMed ID: 16678917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American College of Clinical Pharmacology position statement on the use of microdosing in the drug development process.
    Bertino JS; Greenberg HE; Reed MD;
    J Clin Pharmacol; 2007 Apr; 47(4):418-22. PubMed ID: 17389550
    [No Abstract]   [Full Text] [Related]  

  • 13. PET and drug research and development.
    Fowler JS; Volkow ND; Wang GJ; Ding YS; Dewey SL
    J Nucl Med; 1999 Jul; 40(7):1154-63. PubMed ID: 10405137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on ACCP position statement on the use of microdosing in the drug development process.
    Rowland M
    J Clin Pharmacol; 2007 Dec; 47(12):1595-6; author reply 1597-8. PubMed ID: 18048576
    [No Abstract]   [Full Text] [Related]  

  • 15. Positron emission tomography in drug development.
    Rubin RH; Fischman AJ
    Q J Nucl Med; 1997 Jun; 41(2):171-5. PubMed ID: 9203856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel strategies for microdose studies using non-radiolabeled compounds.
    Maeda K; Sugiyama Y
    Adv Drug Deliv Rev; 2011 Jun; 63(7):532-8. PubMed ID: 21345359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microdosing for early biokinetic studies in humans.
    Stenström K; Sydoff M; Mattsson S
    Radiat Prot Dosimetry; 2010; 139(1-3):348-52. PubMed ID: 20167793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Positron emission tomography in pharmacokinetics and pharmacodynamics].
    Lucignani G; Moresco RM; Fazio F
    Boll Chim Farm; 1993; 132(7):231-3. PubMed ID: 8398055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative small animal PET.
    Shoghi KI
    Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):365-73. PubMed ID: 19834445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Strategy for development of imaging biomarkers].
    Ishiwata K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):67-71. PubMed ID: 19562944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.